Lazard Asset Management
ENZ

Lazard Asset Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Lazard Asset Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-50,453
Closed -$18K – 2580
2025
Q1 		$18K Hold
50,453
– – ﹤0.01% 2119
2024
Q4 		$36K Hold
50,453
– – ﹤0.01% 2028
2024
Q3 		$56K Hold
50,453
– – ﹤0.01% 1899
2024
Q2 		$54K Buy
+50,453
New +$56.8K ﹤0.01% 1921
2024
Q1 		– Sell
-50,453
Closed -$70K – 2431
2023
Q4 		$70K Hold
50,453
– – ﹤0.01% 1802
2023
Q3 		$70K Hold
50,453
– – ﹤0.01% 1758
2023
Q2 		$92K Hold
50,453
– – ﹤0.01% 1613
2023
Q1 		$122K Buy
+50,453
New +$75K ﹤0.01% 1460

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Lazard Asset Management's ENZ Position: Q2 2025 in Review

Lazard Asset Management sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 50,453 shares — an estimated $18K sold.

Lazard Asset Management first reported a position in ENZ in Q1 2023 and held it in 8 quarters. The position peaked at $122K in Q1 2023. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Lazard Asset Management reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Lazard Asset Management sold 50,453 Enzo Biochem, Inc. shares in Q2 2025, an estimated $18K.
  • Lazard Asset Management first reported a position in Enzo Biochem, Inc. in Q1 2023 and held it in 8 quarters.
  • Lazard Asset Management's Enzo Biochem, Inc. position peaked at $122K in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.